As CD200-CD200R signaling has been previously reported to promote an immunosuppressive phenotype in dendritic cells and macrophages [47, 48], the interaction between CD200 + iCAFs and CD200R + myeloid cells may be a mechanism that promotes an immunosuppressive TME in pancreatic cancer. This evidence concerns the gene CD200R1 and pancreatic neoplasm.